CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Intellia Therapeutics, Inc.  (NTLA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
 

NTLA's Revenue Year on Year Growth by Quarter and Year

Intellia Therapeutics,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
NTLA Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 5.63 0.00 0.00
III Quarter September - 4.87 0.00 0.00
II Quarter June 5.92 4.21 0.00 0.00
I Quarter March 6.22 1.78 0.00 0.00
FY   12.14 16.49 - -

Financial Statements
Intellia Therapeutics,'s second quarter 2017 Revenue $ 5.92 millions NTLA's Income Statement
Intellia Therapeutics,'s second quarter 2016 Revenue $ 4.21 millions Quarterly NTLA's Income Statement
NTLA's Growth by Division See NTLA's Growth by Segment

NTLA Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June 40.55 % - - -
I Quarter March 249.44 % - - -
FY   - - - -



NTLA Revenue Growth Comment
Intellia Therapeutics, Inc. reported Revenue rise of 40.55% year on year in the second quarter, to $ 5.92 millions, this is lower than Intellia Therapeutics, Inc.'s recent average Revenue surge of 145.21%.

Looking into second quarter results within Biotechnology & Drugs industry 24 other companies have achieved higher Revenue growth. While Intellia Therapeutics, Inc.' s Revenue jump of 40.55% ranks overall at the positon no. 487 in the second quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #25
Healthcare Sector #93
Overall #487
Revenue Y/Y Growth Statistics
High Average Low
249.75 % 145.21 % 40.68 %
(Mar 31 2017)   (Jun 30 2017)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NTLA's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NTLA's Competitors
Revenue Growth for Intellia Therapeutics,'s Suppliers
Revenue Growth for NTLA's Customers

You may also want to know
NTLA's Annual Growth Rates NTLA's Profitability Ratios NTLA's Asset Turnover Ratio NTLA's Dividend Growth
NTLA's Roe NTLA's Valuation Ratios NTLA's Financial Strength Ratios NTLA's Dividend Payout Ratio
NTLA's Roa NTLA's Inventory Turnover Ratio NTLA's Growth Rates NTLA's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Jun 30 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2017
Nephros Inc  68.76 %$ 68.762 millions
Teladoc, Inc.  68.34 %$ 68.344 millions
Intelgenx Technologies Corp.  67.56 %$ 67.560 millions
Keryx Biopharmaceuticals Inc  63.05 %$ 63.049 millions
Neurometrix, Inc.  62.80 %$ 62.802 millions
Agios Pharmaceuticals Inc  62.60 %$ 62.597 millions
Myokardia Inc  58.50 %$ 58.495 millions
Semler Scientific, Inc.  57.58 %$ 57.579 millions
United Health Products, Inc.  55.73 %$ 55.728 millions
Novabay Pharmaceuticals, Inc.  54.79 %$ 54.788 millions
Shire Plc  54.21 %$ 54.205 millions
Zynex Inc  53.44 %$ 53.439 millions
Flex Pharma, Inc.  52.16 %$ 52.163 millions
Adverum Biotechnologies, Inc.  50.81 %$ 50.814 millions
Adma Biologics, Inc.  49.64 %$ 49.638 millions
Diversicare Healthcare Services, Inc.  48.79 %$ 48.792 millions
Supernus Pharmaceuticals Inc  46.88 %$ 46.881 millions
Axogen, Inc.  46.10 %$ 46.101 millions
Glaukos Corp  44.58 %$ 44.576 millions
Ligand Pharmaceuticals Inc  43.41 %$ 43.410 millions
Albany Molecular Research Inc  43.14 %$ 43.144 millions
Ani Pharmaceuticals Inc  42.85 %$ 42.847 millions
Joway Health Industries Group Inc  42.79 %$ 42.793 millions
Nevro Corp  40.82 %$ 40.823 millions
Intellia Therapeutics, Inc.  40.68 %$ 40.680 millions
Imprimis Pharmaceuticals, Inc.  39.74 %$ 39.739 millions
Sensus Healthcare, Inc.  39.13 %$ 39.128 millions
Durect Corp  36.81 %$ 36.807 millions
Amarin Corp Plcuk  36.63 %$ 36.634 millions
Combimatrix Corp  36.50 %$ 36.498 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SMG's Profile

Stock Price

SMG's Financials

SMG's Expectations

Business Description

Fundamentals

Charts & Quotes

SMG's News

Suppliers

SMG's Competitors

Customers & Markets

Economic Indicators

SMG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com